Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment
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We describe a case of macular hole (MH) closure after intravitreal bevacizumab therapy for an underlying pigment epithelial detachment (PED) due to exudative age-related macular degeneration (AMD). The 73-year-old Caucasian female presented with reduced visual acuity (20/80) of the left eye and metamorphopsia for approximately 6 months. Spectral domain optical coherence tomography revealed a subfoveal PED due to AMD with an associated MH. To treat the exudative component of the pathology, we started intravitreal bevacizumab therapy, consecutively leading to reduction of the height of PED and allowing closure of the MH. Detachment recurred during further follow-up, but the MH remained closed. MHs and exudative AMD are common diseases, which rarely occur simultaneously. To the best of our knowledge (search via PubMed for "MH," "PED," "age-related macular degeneration"), no other case with the persistent closure of an MH associated with PED during intravitreal antivascular endothelial growth factor therapy and despite recurrent PED has been published to date.
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We present the case of a 73-year-old Caucasian female with macular hole (MH) closure after intravitreal bevacizumab therapy for an underlying pigment epithelial detachment (PED) due to exudative age-related macular degeneration (AMD). This case represents the first in literature, though there are several case reports on PED or antivascular endothelial growth factor (VEGF) therapy-associated MHs. [1, 2] 
Case Report
The 73-year-old Caucasian female presented with decreased vision and metamorphopsia for 6 months in her left eye. Initial examination revealed best-corrected visual acuity (BCVA)
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Discussion
MH in the presence of drusen are not rare, and the results of vitreous surgery have been published earlier. [3, 4] In contrast to commonly accepted causative factors such as anteroposterior and tangential vitreous traction forces as in idiopathic MH, [5] intraretinal glial pathology seems to be the prominent cause in secondary holes, such as ruptured cysts in vascular macular edema [6] or glial apoptosis on top of confluent soft drusen. The successful surgical treatment of MHs associated with PED was reported by Raiji et al. [7] and Cazabon, [8] but no report exists on closure of a PED-associated MH by intravitreal anti-VEGF treatment. However, the formation of MH during intravitreal VEGF treatment in patients with PED [1] and rip [2] is already described. The authors proposed vitreous changes, induced by intravitreal injections as a possible pathomechanism. [9] 
Conclusion
In the presented case, it is not known whether the MH was already existing before AMD changes occurred. If it had developed after PED, stretching forces may have played a crucial role in the formation of the MH. A rate of 8.6% spontaneous closure in idiopathic MHs is reported by Chew et al. [10] It usually occurs after spontaneous posterior vitreous detachment. In the presented patient, in OCT images the posterior hyaloid remained attached, however, tangential vitreous traction forces may have released during intravitreal drug treatment. Therefore, in this case, the resolution of PED during anti-VEGF-therapy seemed to release the mechanical stress allowing approximation of the MH-edges and closure of the hole.
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